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1. TOSOH Corporation, 2743-1, Hayakawa, Ayase-shi, Kanagawa, 252-1123, JAPAN 2. Department of Materials Science, Kanagawa University, Tsuchiya, Hiratsuka-shi, Kanagawa, 259-1293, JAPAN Various 1,2-dioxetane derivatives have been synthesized and reported. These 1,2-dioxetanes do not, however, necessarily satisfy the demands, namely high thermal stability, easiness for handling, and high light yield in an aqueous solution, to use in the field of clinical applications. For this reason, we have challenged combinations of several different hydrophobic materials and fluorescent dyes for enhancing light yield in an aqueous solution.
Upon an extensive study, we have reached a new chemiluminescence substrate for the enzyme immunoassay using a new 1,2-dioxetane derivative, 5-t-butyl-4,4-dimethyl-1-(3'-phosphoryloxy)phenyl-2,6,7-trioxabicyclo[3.2.0]heptane disodium salt, in combination with tetra-alkyl phosphonium derivative and fluorescein as an enhancer. Upon optimization of each component concentration, the new substrate has a high light yield with low background by removing impurities using chelateing ion exchange resin. Furthermore, this substrate was found to be stable for more than one month at 40°C and for more than one year at 10°C. In conclusion, our substrate comprised of a new 1,2-dioxetane and an enhancer was found to have excellent characteristics with a high thermal stability and a very high light yield which can be well applied in clinical usage. Chemiluminescence enzyme immunoassay using a new chemiluminescence substrate showed highly sensitive immunoassay with TSH even less than 0.001 µIU/mL.
